Cone Beam CT Scanning in Lung and Bladder Cancer.

Lung Neoplasm Clinical Trial

Official title:

Improving the Accuracy of Radiotherapy Planning and Delivery Using Kilovoltage Cone Beam CT Imaging

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00469066
• Other study ID #: LU-11-0073
• Status: Completed
• Phase: N/A
• First received: May 2, 2007
• Last updated: February 23, 2016
• Start date: May 2007
• Est. completion date: April 2010

Study information

• Verified date: December 2011
• Source: AHS Cancer Control Alberta
• Contact: n/a
• Is FDA regulated: No
• Health authority: Canada: Health Canada
• Study type: Observational

Clinical Trial Summary

To study changes in tumor and normal organ size and/or position which occur during a course of radiation treatments.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 22
• Est. completion date: April 2010
• Est. primary completion date: August 2009
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Patient has biopsy proven limited stage SCLC

• receiving radical concurrent chemoradiotherapy

• no prior chest RT

• no prior surgical resection of lung tumor

• no prior chemotherapy

• patients' lung tumors should be centrally-located to minimize the effect of respiratory motion

• patient has biopsy proven TCC bladder

• receiving radical concurrent chemoradiotherapy or RT alone

• no prior chemotherapy

• patient signs study-specific consent form

Exclusion Criteria:

• mixed small cell and non small cell histology

• patient not being treated with concurrent chemoradiotherapy

• chemoradiotherapy given sequentially

• previous chest RT

• previous chemotherapy

• prior surgical resection of lung mass

• patient ineligible for pelvic RT

• patient does not sign study consent

Study Design

Observational Model: Case-Only, Time Perspective: Prospective

Related Conditions & MeSH terms

• Bladder Carcinoma
• Carcinoma
• Carcinoma, Small Cell
• Lung Neoplasm
• Lung Neoplasms
• Small Cell Carcinoma
• Small Cell Lung Carcinoma
• Urinary Bladder Neoplasms

Locations

Country	Name	City	State
Canada	Cross Cancer Institute	Edmonton	Alberta

Sponsors (2)

Lead Sponsor	Collaborator
AHS Cancer Control Alberta	Cross Cancer Institute

Country where clinical trial is conducted

Canada,